 | • レポートコード：MRC2208A0017 • 出版社/出版日：Transparency Market Research / 2022年6月 • レポート形態：英文、PDF、191ページ • 納品方法：Eメール • 産業分類：医療 |
| Single User | ￥857,660 (USD5,795) | ▷ お問い合わせ |
| Multi User | ￥1,301,660 (USD8,795) | ▷ お問い合わせ |
| Corporate License | ￥1,745,660 (USD11,795) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| Transparency Market Research社の当調査資料では、世界の猫アレルギー市場について広く調査・分析を行い、序論、仮定・調査手法、エグゼクティブサマリー、市場概要、キーインサイト、治療別（抗ヒスタミン剤、コルチコステロイド鼻スプレー、充血除去剤、ロイコトリエン阻害剤、その他）分析、用途別分析、流通チャネル別分析、地域別（北米、ヨーロッパ、アジア太平洋、中南米、中東・アフリカ）分析、競争状況などをまとめました。なお、当書に掲載されている企業情報には、Bayer AG、Covis Pharma B.V、HollisterStier Allergy.、GlaxoSmithKline plc、Merck & Co. Inc.、Regeneron Pharmaceuticals, Inc.、Saiba Animal Health AG、Sanofi, Stallergenes Greerなどが含まれています。 ・序論 ・仮定・調査手法 ・エグゼクティブサマリー ・市場概要 ・キーインサイト ・世界の猫アレルギー市場規模：治療別（抗ヒスタミン剤、コルチコステロイド鼻スプレー、充血除去剤、ロイコトリエン阻害剤、その他） ・世界の猫アレルギー市場規模：用途別 ・世界の猫アレルギー市場規模：流通チャネル別 ・世界の猫アレルギー市場規模：地域別（北米、ヨーロッパ、アジア太平洋、中南米、中東・アフリカ） ・競争状況 |
Cat Allergy in Humans Market – Scope of Report
TMR’s report on the global cat allergy in humans market studies the past as well as the current growth trends and opportunities to gain valuable insights of the indicators of the market during the forecast period from 2022 to 2031. The report provides revenue of the global cat allergy in humans market for the period 2017–2031, considering 2021 as the base year and 2031 as the forecast year. The report also provides the compound annual growth rate (CAGR %) of the global cat allergy in humans market from 2022 to 2031.
The report has been prepared after an extensive research. Primary research involved bulk of the research efforts, wherein analysts carried out interviews with key opinion leaders, industry leaders, and opinion makers. Secondary research involved referring to key players’ product literature, annual reports, press releases, and relevant documents to understand the cat allergy in humans market.
Secondary research also included Internet sources, statistical data from government agencies, websites, and trade associations. Analysts employed a combination of top-down and bottom-up approaches to study various attributes of the global cat allergy in humans market.
The report includes an elaborate executive summary, along with a snapshot of the growth behavior of various segments included in the scope of the study. Moreover, the report sheds light on the changing competitive dynamics in the global cat allergy in humans market. These serve as valuable tools for existing market players as well as for entities interested in participating in the global cat allergy in humans market.
The report delves into the competitive landscape of the global cat allergy in humans market. Key players operating in the global cat allergy in humans market have been identified and each one of these has been profiled, in terms of various attributes. Company overview, financial standings, recent developments, and SWOT are attributes of players in the global cat allergy in humans market profiled in this report.
RESEARCH METHODOLOGY
The research methodology will be a combination of exhaustive primary and secondary research to analyze the market cat allergy in humans.
Secondary Research
Secondary research includes a search of company literature, technical writing, patent data, Internet sources, and statistical data from government websites, trade associations, and agencies. This has proven to be the most reliable, effective, and successful approach for obtaining precise data, capturing industry participants’ insights, and recognizing business opportunities.
Secondary research sources that we typically refer, but are not limited to:
Company websites, presentations, annual reports, white papers, technical paper, product brochure
Internal and external proprietary databases and relevant patents
National government documents, statistical databases, and market reports
News articles, press releases, and webcasts specific to companies operating in the market
Specific Secondary Sources:
Industry Sources:
WorldWideScience.org
Elsevier, Inc.
National Institutes of Health (NIH)
PubMed
NCBI
Department of Health Care Service
Trade Data Sources
Trade Map
UN Comtrade
Trade Atlas
Company Information
OneSource Business Browser
Hoover’s
Factiva
Bloomberg
Mergers & Acquisitions
Thomson Mergers & Acquisitions
MergerStat
Profound
Primary Research
During the course of research, we conduct in-depth interviews and discussions with a wide range of key industry participants and opinion leaders. Primary research represents bulk of research efforts, supplemented by extensive secondary research.
We conduct primary interviews on the ongoing basis with industry participants and commentators to validate data and analysis. A typical research interview fulfills the following functions:
Provides first-hand information on market size, market trends, growth trends, competitive landscape, outlook, etc.
Helps in validating and strengthening secondary research findings
Further develops the analysis team’s expertise and market understanding
Primary research involves e-mail interactions, telephonic interviews, as well as face-to-face interviews for each market, category, segment, and sub-segment across geographies
Participants who typically take part in such a process include, but are not limited to:
Industry participants: Marketing/product managers, market intelligence managers, and regional sales managers
Purchasing/Sourcing managers, technical personnel, distributors
Outside experts: Investment bankers, valuation experts, and research analysts specializing in specific markets
Key opinion leaders specializing in different areas corresponding to different industry verticals
List of primary participants, but not limited to:
Advanced Oncotherapy PLC
Danfysik A/S
Hitachi, Ltd.
IBA Worldwide
Mevion Medical Systems, Inc.
Data Triangulation: Information culled from “Secondary & Primary Sources” is cross-checked with “TMR Knowledge Repository”, which is updated every quarter.
Market Estimation: Market size estimations involved in-depth study of product features, technology updates, geographic presence, product demand, sales data (value or volume), historical year-on-year growth, and others. Other approaches were also utilized to derive market size and forecasts. Where no hard data was available, we employed modeling techniques in order to produce comprehensive datasets. A rigorous methodology has been adopted, wherein the available hard data are cross-referenced with the following data types to produce estimates:
Demographic Data: Healthcare expenditure, inflation rates, and others
Industry Indicators: R&D investment, technology stage, and infrastructure, sector growth, and facilities
Market Forecasting: Market forecasts for various segments are derived taking into account drivers, restraints/challenges, and opportunities prevailing in the market and considering advantages/disadvantages of segments/sub-segments over other segments/sub-segments. Business environment, historical sales pattern, unmet needs, competitive intensity, and country-wise surgery data are some of the other pivotal factors, which are considered to derive market forecasts.
レポート目次1. Preface
1.1. Market Definition and Scope
1.2. Market Segmentation
1.3. Key Research Objectives
1.4. Research Highlights
2. Assumptions and Research Methodology
3. Executive Summary : Global Cat Allergy in Humans Market
4. Market Overview
4.1. Introduction
4.1.1. Definition
4.1.2. Industry Evolution / Developments
4.2. Overview
4.3. Market Dynamics
4.3.1. Drivers
4.3.2. Restraints
4.3.3. Opportunities
4.4. Global Cat Allergy in Humans Market Analysis and Forecasts, 2017–2031
5. Key Insights
5.1. Key Mergers & Acquisitions
5.2. Allergy Prevalence Data
5.3. Pipeline Analysis
5.4. COVID-19 Pandemic Impact on Industry (Value Chain and Short / Mid / Long Term Impact)
6. Global Cat Allergy in Humans Market Analysis and Forecasts, By Treatment
6.1. Introduction & Definition
6.2. Key Findings / Developments
6.3. Market Value Forecast By Treatment, 2017–2031
6.3.1.1. Antihistamines
6.3.2. Corticosteroid Nasal Sprays
6.3.3. Decongestants
6.3.4. Leukotriene Inhibitors
6.3.5. Others
6.4. Market Attractiveness By Treatment
7. Global Cat Allergy in Humans Market Analysis and Forecasts, By Application
7.1. Introduction & Definition
7.2. Key Findings / Developments
7.3. Market Value Forecast By Application, 2017–2031
7.3.1. Allergy Treatment
7.3.2. Allergy Prevention
7.4. Market Attractiveness By Application
8. Global Cat Allergy in Humans Market Analysis and Forecasts, By Distribution Channel
8.1. Introduction & Definition
8.2. Key Findings / Developments
8.3. Market Value Forecast By Distribution Channel, 2017–2031
8.3.1. Hospital pharmacies
8.3.2. Retail pharmacies
8.3.3. Online Pharmacies
8.4. Market Attractiveness By Distribution Channel
9. Global Cat Allergy in Humans Market Analysis and Forecasts, By Region
9.1. Key Findings
9.2. Market Value Forecast By Region
9.2.1. North America
9.2.2. Europe
9.2.3. Asia Pacific
9.2.4. Latin America
9.2.5. Middle East & Africa
9.3. Market Attractiveness By Country/Region
10. North America Cat Allergy in Humans Market Analysis and Forecast
10.1. Introduction
10.1.1. Key Findings
10.2. Market Value Forecast By Treatment, 2017–2031
10.2.1. Antihistamines
10.2.2. Corticosteroid Nasal Sprays
10.2.3. Decongestants
10.2.4. Leukotriene Inhibitors
10.2.5. Others
10.3. Market Value Forecast By Application, 2017–2031
10.3.1. Allergy Treatment
10.3.2. Allergy Prevention
10.4. Market Value Forecast By Distribution Channel, 2017–2031
10.4.1. Hospital pharmacies
10.4.2. Retail pharmacies
10.4.3. Online Pharmacies
10.5. Market Value Forecast By Country, 2017–2031
10.5.1. U.S.
10.5.2. Canada
10.6. Market Attractiveness Analysis
10.6.1. By Treatment
10.6.2. By Application
10.6.3. By Distribution Channel
10.6.4. By Country
11. Europe Cat Allergy in Humans Market Analysis and Forecast
11.1. Introduction
11.1.1. Key Findings
11.2. Market Value Forecast By Treatment, 2017–2031
11.2.1. Antihistamines
11.2.2. Corticosteroid Nasal Sprays
11.2.3. Decongestants
11.2.4. Leukotriene Inhibitors
11.2.5. Others
11.3. Market Value Forecast By Application, 2017–2031
11.3.1. Allergy Treatment
11.3.2. Allergy Prevention
11.4. Market Value Forecast By Distribution Channel, 2017–2031
11.4.1. Hospital pharmacies
11.4.2. Retail pharmacies
11.4.3. Online Pharmacies
11.5. Market Value Forecast By Country, 2017–2031
11.5.1. Germany
11.5.2. U.K.
11.5.3. France
11.5.4. Italy
11.5.5. Spain
11.5.6. Rest of Europe
11.6. Market Attractiveness Analysis
11.6.1. By Treatment
11.6.2. By Application
11.6.3. By Distribution Channel
11.6.4. By Country
12. Asia Pacific Cat Allergy in Humans Market Analysis and Forecast
12.1. Introduction
12.1.1. Key Findings
12.2. Market Value Forecast By Treatment, 2017–2031
12.2.1. Antihistamines
12.2.2. Corticosteroid Nasal Sprays
12.2.3. Decongestants
12.2.4. Leukotriene Inhibitors
12.2.5. Others
12.3. Market Value Forecast By Application, 2017–2031
12.3.1. Allergy Treatment
12.3.2. Allergy Prevention
12.4. Market Value Forecast By Distribution Channel, 2017–2031
12.4.1. Hospital pharmacies
12.4.2. Retail pharmacies
12.4.3. Online Pharmacies
12.5. Market Value Forecast By Country, 2017–2031
12.5.1. China
12.5.2. Japan
12.5.3. India
12.5.4. Australia & New Zealand
12.5.5. Rest of Asia Pacific
12.6. Market Attractiveness Analysis
12.6.1. By Treatment
12.6.2. By Application
12.6.3. By Distribution Channel
12.6.4. By Country
13. Latin America Cat Allergy in Humans Market Analysis and Forecast
13.1. Introduction
13.1.1. Key Findings
13.2. Market Value Forecast By Treatment, 2017–2031
13.2.1. Antihistamines
13.2.2. Corticosteroid Nasal Sprays
13.2.3. Decongestants
13.2.4. Leukotriene Inhibitors
13.2.5. Others
13.3. Market Value Forecast By Application, 2017–2031
13.3.1. Allergy Treatment
13.3.2. Allergy Prevention
13.4. Market Value Forecast By Distribution Channel, 2017–2031
13.4.1. Hospital pharmacies
13.4.2. Retail pharmacies
13.4.3. Online Pharmacies
13.5. Market Value Forecast By Country, 2017–2031
13.5.1. Brazil
13.5.2. Mexico
13.5.3. Rest of Latin America
13.6. Market Attractiveness Analysis
13.6.1. By Treatment
13.6.2. By Application
13.6.3. By Distribution Channel
13.6.4. By Country
14. Middle East & Africa Cat Allergy in Humans Market Analysis and Forecast
14.1. Introduction
14.1.1. Key Findings
14.2. Market Value Forecast By Treatment, 2017–2031
14.2.1. Antihistamines
14.2.2. Corticosteroid Nasal Sprays
14.2.3. Decongestants
14.2.4. Leukotriene Inhibitors
14.2.5. Others
14.3. Market Value Forecast By Application, 2017–2031
14.3.1. Allergy Treatment
14.3.2. Allergy Prevention
14.4. Market Value Forecast By Distribution Channel, 2017–2031
14.4.1. Hospital pharmacies
14.4.2. Retail pharmacies
14.4.3. Online Pharmacies
14.5. Market Value Forecast By Country, 2017–2031
14.5.1. GCC Countries
14.5.2. South Africa
14.5.3. Rest of Middle East & Africa
14.6. Market Attractiveness Analysis
14.6.1. By Treatment
14.6.2. By Application
14.6.3. By Distribution Channel
14.6.4. By Country
15. Competition Landscape
15.1. Market Player – Competition Matrix (by tier and size of companies)
15.2. Market Share Analysis, by Company, 2020
15.3. Company Profiles
15.3.1. Bayer AG
15.3.1.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.1.2. Product Portfolio
15.3.1.3. SWOT Analysis
15.3.1.4. Strategic Overview
15.3.2. Covis Pharma B.V
15.3.2.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.2.2. Product Portfolio
15.3.2.3. SWOT Analysis
15.3.2.4. Strategic Overview
15.3.3. HollisterStier Allergy.
15.3.3.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.3.2. Product Portfolio
15.3.3.3. SWOT Analysis
15.3.3.4. Strategic Overview
15.3.4. GlaxoSmithKline plc
15.3.4.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.4.2. Product Portfolio
15.3.4.3. SWOT Analysis
15.3.4.4. Strategic Overview
15.3.5. Merck & Co. Inc.
15.3.5.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.5.2. Product Portfolio
15.3.5.3. SWOT Analysis
15.3.5.4. Strategic Overview
15.3.6. Regeneron Pharmaceuticals, Inc.
15.3.6.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.6.2. Product Portfolio
15.3.6.3. SWOT Analysis
15.3.6.4. Strategic Overview
15.3.7. Saiba Animal Health AG
15.3.7.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.7.2. Product Portfolio
15.3.7.3. SWOT Analysis
15.3.7.4. Strategic Overview
15.3.8. Sanofi, Stallergenes Greer
15.3.8.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.8.2. Product Portfolio
15.3.8.3. SWOT Analysis
15.3.8.4. Strategic Overview
Table 01: Global Cat Allergy in Humans Market Value (US$ Mn) Forecast, by Treatment, 2017‒2031
Table 02: Global Cat Allergy in Humans Market Value (US$ Mn) Forecast, by Antihistamines, 2017‒2031
Table 03: Global Cat Allergy in Humans Market Value (US$ Mn) Forecast, by Application, 2017–2031
Table 04: Global Cat Allergy in Humans Market Value (US$ Mn) Forecast, by Distribution Channel, 2017–2031
Table 05: Global Cat Allergy in Humans Market Value (US$ Mn) Forecast, by Region, 2017–2031
Table 06: North America Cat Allergy in Humans Market Value (US$ Mn) Forecast, by Country, 2017–2031
Table 07: North America Cat Allergy in Humans Market Value (US$ Mn) Forecast, by Treatment, 2017‒2031
Table 08: North America Cat Allergy in Humans Market Value (US$ Mn) Forecast, by Antihistamines, 2017‒2031
Table 09: North America Cat Allergy in Humans Market Value (US$ Mn) Forecast, by Application, 2017–2031
Table 10: North America Cat Allergy in Humans Market Value (US$ Mn) Forecast, by Distribution Channel, 2017–2031
Table 11: Europe Cat Allergy in Humans Market Value (US$ Mn) Forecast, by Country/Sub-Region, 2017–2031
Table 12: Europe Cat Allergy in Humans Market Value (US$ Mn) Forecast, by Treatment, 2017‒2031
Table 13: Europe Cat Allergy in Humans Market Value (US$ Mn) Forecast, by Antihistamines, 2017‒2031
Table 14: Europe Cat Allergy in Humans Market Value (US$ Mn) Forecast, by Application, 2017–2031
Table 15: Europe Cat Allergy in Humans Market Value (US$ Mn) Forecast, by Distribution Channel, 2017–2031
Table 16: Asia Pacific Cat Allergy in Humans Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2031
Table 17: Asia-Pacific Cat Allergy in Humans Market Value (US$ Mn) Forecast, by Treatment, 2017‒2031
Table 18: Asia-Pacific Cat Allergy in Humans Market Value (US$ Mn) Forecast, by Antihistamines, 2017‒2031
Table 19: Asia-Pacific Cat Allergy in Humans Market Value (US$ Mn) Forecast, by Application, 2017–2031
Table 20: Asia-Pacific Cat Allergy in Humans Market Value (US$ Mn) Forecast, by Distribution Channel, 2017–2031
Table 21: Latin America Cat Allergy in Humans Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017-2031
Table 22: Latin America Cat Allergy in Humans Market Value (US$ Mn) Forecast, by Treatment, 2017‒2031
Table 23: Latin America Cat Allergy in Humans Market Value (US$ Mn) Forecast, by Antihistamines, 2017‒2031
Table 24: Latin America Cat Allergy in Humans Market Value (US$ Mn) Forecast, by Application, 2017–2031
Table 25: Latin America Cat Allergy in Humans Market Value (US$ Mn) Forecast, by Distribution Channel, 2017–2031
Table 26: Middle East & Africa Cat Allergy in Humans Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017-2031
Table 27: Middle East & Africa Cat Allergy in Humans Market Value (US$ Mn) Forecast, by Treatment, 2017‒2031
Table 28: Middle East & Africa Cat Allergy in Humans Market Value (US$ Mn) Forecast, by Antihistamines, 2017‒2031
Table 29: Middle East & Africa Cat Allergy in Humans Market Value (US$ Mn) Forecast, by Application, 2017–2031
Table 30: Middle East & Africa Cat Allergy in Humans Market Value (US$ Mn) Forecast, by Distribution Channel, 2017–2031